Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
46.6 EUR | +3.93% | +7.23% | -4.27% |
Apr. 24 | COVIVIO : Invest Securities remains Buy after sales release | CF |
Apr. 24 | Covivio: stable revenues in Q1 | CF |
Sales 2024 * | 1.08B 1.15B | Sales 2025 * | 1.09B 1.17B | Capitalization | 4.67B 4.99B |
---|---|---|---|---|---|
Net income 2024 * | 118M 126M | Net income 2025 * | 499M 534M | EV / Sales 2024 * | 10.3 x |
Net Debt 2024 * | 6.44B 6.89B | Net Debt 2025 * | 6.31B 6.75B | EV / Sales 2025 * | 10.1 x |
P/E ratio 2024 * |
47
x | P/E ratio 2025 * |
9.34
x | Employees | - |
Yield 2024 * |
7.32% | Yield 2025 * |
7.38% | Free-Float | 67.78% |
Latest transcript on Covivio
1 day | +3.93% | ||
1 week | +7.23% | ||
Current month | -2.31% | ||
1 month | +1.92% | ||
3 months | +2.15% | ||
6 months | +24.40% | ||
Current year | -4.27% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 01-09-30 | |
Paul Arkwright
DFI | Director of Finance/CFO | 38 | 13-12-31 |
Chief Tech/Sci/R&D Officer | 36 | 18-02-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 70 | 11-01-30 | |
Olivier Piani
BRD | Director/Board Member | 70 | 19-04-16 |
Chief Executive Officer | 58 | 01-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.43% | 2 M€ | +7.72% | ||
0.31% | 208 M€ | -.--% | ||
0.30% | 285 M€ | -3.89% | ||
0.22% | 182 M€ | +6.98% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 46.6 | +3.93% | 155,207 |
24-04-25 | 44.84 | 0.00% | 196,077 |
24-04-24 | 44.84 | 0.00% | 186,972 |
24-04-23 | 44.84 | +0.99% | 162,237 |
24-04-22 | 44.4 | +2.16% | 161,528 |
Real-time Euronext Paris, April 26, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.27% | 4.98B | |
-6.46% | 46.25B | |
-8.31% | 20.33B | |
-3.56% | 13.07B | |
+16.05% | 11.53B | |
-4.85% | 9.68B | |
-0.83% | 8.48B | |
-14.19% | 8.38B | |
+1.38% | 7.63B | |
-18.42% | 5.53B |
- Stock Market
- Equities
- COV Stock